BioCentury
ARTICLE | Clinical News

Narcan naloxone regulatory update

November 23, 2015 8:00 AM UTC

FDA approved Narcan naloxone nasal spray for the emergency treatment of known or suspected opioid overdose. Adapt has worldwide rights to develop and commercialize the opioid antagonist nasal spray f...